Stocks making the biggest moves midday: Novavax, Darden Restaurants, Eli Lilly and more

Market Insider

In this article

An Olive Garden restaurant in Times Square in New York.
Richard Levine | Corbis | Getty Images

Here are the stocks making headlines in midday trading Thursday.

Novavax — Shares of the drug maker tumbled 13.9% after JPMorgan downgraded Novavax to underweight from neutral. The banks also slashed its price target on the stock, citing dwindling demand for Covid-19 vaccines.

Darden Restaurants — Shares of Olive Garden’s parent company fell more than 4% after Darden’s fiscal first-quarter results showed lighter-than-expected revenue. The company reported $1.56 in earnings per share on $2.45 billion of revenue. Analysts surveyed by Refinitiv had penciled in $1.56 per share on $2.47 billion of revenue. Same store sales at Olive Garden rose just 2% year over year.

Eli Lilly — The pharmaceutical stock climbed 4.2% after UBS upgraded Eli Lilly to buy from neutral. UBS said that Eli Lily’s new weight loss product could be “the biggest drug ever.”

KB Home – Shares of homebuilder KB Home slipped 4% after the company reported earnings that disappointed Wall Street’s revenue expectations. The company reported earnings of $2.86 per share on $1.85 billion in revenue, where analysts surveyed by Refinitiv expected earnings of $2.67 per share and $1.87 billion in revenue.

Lennar — Shares of Lennar rose 2.5% after the company reported mixed quarterly results on Wednesday. The home construction company reported earnings of $5.03 per share and $8.93 in revenue, where analysts surveyed by Refinitiv expected $4.88 in earnings on $9 billion in revenue. KeyBanc said in a note to clients that Lennar “optimizes asset turns” better than competitors even as housing demand slows.

FactSet — Shares of the financial data company slumped more than 6% after FactSet’s fourth-quarter earnings came in short of expectations. The company reported $3.13 in adjusted earnings per share, below the $3.20 anticipated by analysts, according to Refinitiv. Revenue did beat expectations by $12 million, coming in at $499 million. FactSet’s operating margin shrank year over year.

Block — The payments platform tumbled 6.8% after Mizuho downgraded shares to neutral from buy and slashed its price target to $57 from $125, saying Block’s bitcoin focus is causing the company to lose focus on its main business.

Steelcase — Shares dropped 11.3% after the furniture company announced it will cut 180 salaried positions in the third quarter. In a statement, Steelcase CFO Dave Sylvester cited “recent volume decline in our incoming orders and lower than expected return-to-office trends in the Americas.” The company also reported its second-quarter results, saying organic order growth in the second quarter declined in the Asia Pacific region even as total revenue grew.

Trip.com — The U.S-traded shares of the Chinese travel company rose 5% despite Trip.com reporting shrinking revenue in the second quarter. Trip.com did report a much smaller net loss than in the first quarter. CEO Jane Sun said that bookings rebounded at the end of the second quarter and into the third.

Deutsche Bank — The bank’s shares rose 2.9%. CFO James von Moltke was reported saying at a conference Thursday that the bank will need to look at 2023 “with caution.” Dow Jones reported that company management also confirmed its full-year revenue guidance.

Virtu Financial — The market maker climbed 8% on a report that the Securities and Exchange Commission won’t ban the Wall Street practice of “payment for order flow.”

Alcoa — The aluminum maker’s stock fell more than 3% after Wolfe Research downgraded Alcoa to peer perform from outperform, citing the macro pressures on the commodity markets.

Li Auto — The stock jumped 6.5% after the Chinese electric vehicle manufacturer announced an “early launch” of Li L8, a smart SUV model. Li Auto is hosting a launch event on September 30, and plans to start delivery in early November.

— CNBC’s Scott Schnipper, Sarah Min, Samantha Subin, Alex Harring and Carmen Reinecke contributed to this report.

Articles You May Like

Cryptocurrency Exchanges: What They Are and How To Choose
The 7 Best Biotech Stocks to Buy
Can Cloud Computing ETFs Keep Soaring?
3 Penny Stocks to Buy During a Stock Market Crash
7 Safe Stocks to Rely on When the Market Swerves